400
Participants
Start Date
May 31, 2007
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
FMP2.1/AS02A
3 doses administered a month apart: 50 µg recombinant subunit protein FMP2.1 (Plasmodium falciparum Apical Membrane Antigen-1 from strain 3D7 expressed in and purified from Escherichia coli), adjuvanted with 0.5 mL of AS02A (proprietary oil-in-water emulsion and phosphate buffered saline with the immunostimulants monophosphoral lipid A and QS21).
Rabies Vaccine
White, freeze-dried vaccine for reconstitution with the diluent prior to use; dosage 1.0 mL of rabies vaccine.
University of Bamako, Malaria Research and Training Center, Bamako
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Walter Reed Army Institute of Research (WRAIR)
FED
GlaxoSmithKline
INDUSTRY
University of Maryland
OTHER
U.S. Army Medical Research and Development Command
FED